Prof Gavin Churchyard - The Aurum Institute

Statement on The Lancet Commission on Tuberculosis: Building a TB-Free World

March 20, 2019—Ahead of World TB Day, we welcome the release today of the report from Lancet Commission on Tuberculosis, which provides a much-needed framework for delivering on the political commit...
Q&A: Locally led leadership key to global health solutions

This article was originally published in Devex on 15 November 2021 It’s time for low-income countries on the African continent and elsewhere to stand up and take on leadership in finding globa...
Aurum at Forum on Microbial Threats workshop

Aurum Group CEO Prof Gavin Churchyard presented at the Forum on Microbial Threats workshop recently. The Forum which is part of the National Academies of Sciences, Engineering, and Medicine, brought...
Watch: Prof Gavin Churchyard at CROI

Professor Gavin Churchyard, Group Chief Executive Officer, recently presented a plenary lecture at the Conference on Retroviruses and Opportunistic Infections (CROI). In this session Churchyard shar...
Preventing TB: a big drug price cut paves the way for global scale-up

This article was published in The Conversation on 13 January 2020. Lengthy negotiations ended in good news recently when the price of rifapentine, a lifesaving antibiotic, was marked down by 66% by i...
Press Statement: Global Consortium welcomes reduced price for patient-friendly treatment to prevent tuberculosis

The Aurum Institute and its partners also announce the launch of the next phase of work to improve access to shorter TB prevention treatments for children and pregnant women Johannesburg, 3 Aug...
Aurum at Union Conference 2023

We are excited to announce our participation in this year's Union World Conference on Lung Health, which will take place in person from November 15th to 18th at the Palais des Congrès in Paris.The Co...
TB prevention must be a priority during COVID-19

Members in Action highlights the many areas of work that our members are championing to ensure a better future in lung health. From our Regions, Scientific Sections and member working groups, to the ...
Prevention has to be a priority for all diseases, not just the pandemic of the moment

...
An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19

Chimoyi, L., Velen, K., Churchyard, G.J., Wallis, R., Lewis, J.J. and Charalambous, S., 2020. An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of ...
Cost-effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda. J Int AIDS Society 2020

Ferguson, O., Jo, Y., Pennington, J., Johnson, K., Chaisson, R.E., Churchyard, G. and Dowdy, D., 2020. Cost‐effectiveness of one month of daily isoniazid and rifapentine versus three months of weekl...
Cost-effectiveness of a 12 country-intervention to scale up short course TB preventive therapy among people living with HIV. J Int AIDS Soc 2020

Shin, H., Jo, Y., Chaisson, R.E., Turner, K., Churchyard, G. and Dowdy, D.W., 2020. Cost‐effectiveness of a 12 country‐intervention to scale up short course TB preventive therapy among people livi...
New TB treatment to cut pill intake by two-thirds: researchers

...
Ghana to benefit from new affordable patient-friendly TB preventive therapy

...
A new TB preventive therapy aims to increase patient compliance

...
Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial

Scriba, T.J., Fiore-Gartland, A., Penn-Nicholson, A., Mulenga, H., Mbandi, S.K., Borate, B., Mendelsohn, S.C., Hadley, K., Hikuam, C., Kaskar, M. and Musvosvi, M., 2021. Biomarker-guided tuberculosis ...
An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19

Chimoyi, L., Velen, K., Churchyard, G.J., Wallis, R., Lewis, J.J. and Charalambous, S., 2020. An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of ...
Digital chest radiography enhances screening efficiency for pulmonary tuberculosis in primary health clinics, South Africa.

Moodley, N., Velen, K., Saimen, A., Zakhura, N., Churchyard, G. and Charalambous, S., 2021. Digital chest radiography enhances screening efficiency for pulmonary tuberculosis in primary health clinics...
Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis.

Foster, N., Cunnama, L., McCarthy, K., Ramma, L., Siapka, M., Sinanovic, E., Churchyard, G., Fielding, K., Grant, A.D. and Cleary, S., 2021. Strengthening health systems to improve the value of tuberc...
Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study.

Mendelsohn, S.C., Fiore-Gartland, A., Penn-Nicholson, A., Mulenga, H., Mbandi, S.K., Borate, B., Hadley, K., Hikuam, C., Musvosvi, M., Bilek, N. and Erasmus, M., 2021. Validation of a host blood trans...

Statement on The Lancet Commission on Tuberculosis: Building a TB-Free World

Q&A: Locally led leadership key to global health solutions

Aurum at Forum on Microbial Threats workshop

Watch: Prof Gavin Churchyard at CROI

Preventing TB: a big drug price cut paves the way for global scale-up

Press Statement: Global Consortium welcomes reduced price for patient-friendly treatment to prevent tuberculosis

Aurum at Union Conference 2023

TB prevention must be a priority during COVID-19

Prevention has to be a priority for all diseases, not just the pandemic of the moment

An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19

Cost-effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda. J Int AIDS Society 2020

Cost-effectiveness of a 12 country-intervention to scale up short course TB preventive therapy among people living with HIV. J Int AIDS Soc 2020

New TB treatment to cut pill intake by two-thirds: researchers

Ghana to benefit from new affordable patient-friendly TB preventive therapy

A new TB preventive therapy aims to increase patient compliance

Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial

An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19

Digital chest radiography enhances screening efficiency for pulmonary tuberculosis in primary health clinics, South Africa.

Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis.

Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study.

Popular Tags

Most Read

Recent Posts